{"count": 3, "results": [{"_id": "32842783", "pmid": 32842783, "title": "Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design.", "journal": "Future Cardiol", "authors": ["Spartalis M", "Tzatzaki E", "Iliopoulos DC", "Spartalis E", "Patelis N", "Athanasiou A", "Paschou SA", "Voudris V", "Siasos G"], "date": "2021-03-01T00:00:00Z", "doi": "10.2217/fca-2020-0062", "meta_date_publication": "2021 Mar", "meta_volume": "17", "meta_issue": "2", "meta_pages": "189-195", "score": 50277.637, "text_hl": "@CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@Captopril@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ to prevent expansion rate of @<m>DISEASE_Aortic_Aneurysm_Thoracic</m> @DISEASE_MESH:D017545 @@@thoracic aortic aneurysms@@@: rationale and design.", "citations": {"NLM": "Spartalis M, Tzatzaki E, Iliopoulos DC, Spartalis E, Patelis N, Athanasiou A, Paschou SA, Voudris V, Siasos G. Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design. Future Cardiol. 2021 Mar;17(2):189-195. PMID: 32842783", "BibTeX": "@article{32842783, title={Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design.}, author={Spartalis M and Tzatzaki E and Iliopoulos DC and Spartalis E and Patelis N and Athanasiou A and Paschou SA and Voudris V and Siasos G}, journal={Future Cardiol}, volume={17}, number={2}, pages={189-195}}"}}, {"_id": "35501038", "pmid": 35501038, "title": "An assessment of the current medical management of thoracic aortic disease: A patient-centered scoping literature review.", "journal": "Semin Vasc Surg", "authors": ["Pena RCF", "Hofmann Bowman MA", "Ahmad M", "Pham J", "Kline-Rogers E", "Case MJ", "Lee J", "Eagle K", "Aortic Dissection Collaborative"], "date": "2022-03-01T00:00:00Z", "doi": "10.1053/j.semvascsurg.2022.02.007", "meta_date_publication": "2022 Mar", "meta_volume": "35", "meta_issue": "1", "meta_pages": "16-34", "score": 50247.97, "text_hl": "...@<m>DISEASE_Aortic_Aneurysm_Thoracic</m> @DISEASE_MESH:D017545 @@@Thoracic aortic aneurysm@@@ and @DISEASE_Aortic_Dissection @DISEASE_MESH:D000784 @@@dissection@@@ are complex diagnoses that require management by multidisciplinary providers using a variety of medical therapies, surgical interventions, and lifestyle modifications. ", "citations": {"NLM": "Pena RCF, Hofmann Bowman MA, Ahmad M, Pham J, Kline-Rogers E, Case MJ, Lee J, Eagle K, Aortic Dissection Collaborative. An assessment of the current medical management of thoracic aortic disease: A patient-centered scoping literature review. Semin Vasc Surg. 2022 Mar;35(1):16-34. PMID: 35501038", "BibTeX": "@article{35501038, title={An assessment of the current medical management of thoracic aortic disease: A patient-centered scoping literature review.}, author={Pena RCF and Hofmann Bowman MA and Ahmad M and Pham J and Kline-Rogers E and Case MJ and Lee J and Eagle K and Aortic Dissection Collaborative}, journal={Semin Vasc Surg}, volume={35}, number={1}, pages={16-34}}"}}, {"_id": "18388324", "pmid": 18388324, "title": "Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.", "journal": "Circ Res", "authors": ["Chung AW", "Yang HH", "Radomski MW", "van Breemen C"], "date": "2008-04-25T00:00:00Z", "doi": "10.1161/CIRCRESAHA.108.174367", "meta_date_publication": "2008 Apr 25", "meta_volume": "102", "meta_issue": "8", "meta_pages": "e73-85", "score": 50066.734, "text_hl": "...Beta-blockers, eg, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, are the cornerstone therapy for @<m>DISEASE_Aortic_Aneurysm_Thoracic</m> @DISEASE_MESH:D017545 @@@thoracic aortic aneurysm@@@ (@<m>DISEASE_Aortic_Aneurysm_Thoracic</m> @DISEASE_MESH:D017545 @@@TAA@@@) in @SPECIES_9606 @@@patients@@@ with @DISEASE_Marfan_Syndrome @DISEASE_MESH:D008382 @@@Marfan syndrome@@@; however, continued @DISEASE_Cardiomyopathy_Dilated @DISEASE_MESH:D002311 @@@aortic dilatation@@@ has been reported. ", "citations": {"NLM": "Chung AW, Yang HH, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res. 2008 Apr 25;102(8):e73-85. PMID: 18388324", "BibTeX": "@article{18388324, title={Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.}, author={Chung AW and Yang HH and Radomski MW and van Breemen C}, journal={Circ Res}, volume={102}, number={8}, pages={e73-85}}"}}]}